RecruitingNot Applicable

Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak

Ukraine100 participantsStarted 2025-12-01

Plain-language summary

The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following: Primary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients who developed esophago-jejunal anastomotic leak less than 50% of circumference of anastomosis * patients who developed esophago-jejunal anastomotic leak and remained stable at the moment of diagnosis with no indications for diversion surgery Exclusion Criteria: * unstable patients who developed esophago-jejunal anastomotic leak * patients who developed esophago-jejunal anastomotic leak more than 50% or anastomotic circumference * patients who rejected endoscopic vacuum therapy

What they're measuring

Mortality rate

Timeframe: 90 days after last endo-vac placement

Trial details

NCT IDNCT07295236

SponsorUkrainian Society of Clinical Oncology

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-12-01

Contact for this trial

Oleksii Dobrzhanskyi, MD

+380638760185 alekseydobrzhanskiy@gmail.com

View on ClinicalTrials.gov More Esophagojejunal Anastomotic Leak trials